Publications and workshops

1. Characterization of GYP*Mur and novel GYP*Bun‐like hybrids in Thai blood donors reveals a qualitatively altered s antigen. Jongruamklang, P., Grimsley, S., Thornton, N., Robb, J., Olsson, M.L. and Storry, J.R. (2020), Vox Sang, 115: 472-477. Original paper.
   
   
2. Disruption of the tumour-associated EMP3 enhances erythroid proliferation and causes the MAM-negative phenotype. Thornton, N., Karamatic Crew, V., Tilley, L.  Green, C.A., Tay, C.L., Griffiths, R.E., Singleton, B.K., Spring, F., Walser, P., Alattar, A.G., Jones, B., Laundy, R., Storry, J.R., Möller, M., Wall, L., Charlewood, R., Westhoff, C.M., Lomas-Francis, C., Yahalom, V., Feick, U., Seltsam, A., Mayer, B., Olsson, M.L. and Anstee, D.J. Nat Commun 11, 3569 (2020). Original paper.
   
   
3. On behalf of the Blood Transfusion Genomics Consortium, Development and validation of a universal blood donor genotyping platform: a multinational prospective study. Nicholas S. Gleadall, Barbera Veldhuisen, Jeremy Gollub, Adam S. Butterworth, John Ord, Christopher J. Penkett, Tiffany C. Timmer, Carolin M. Sauer, Nieke van der Bolt, Colin Brown, Kim Brugger, Alexander T. Dilthey, Daniel Duarte, Shane Grimsley, Katja van den Hurk, John M. Jongerius, Jessie Luken, Karyn Megy, Gail Miflin, Christopher S. Nelson, Femmeke J. Prinsze, Jennifer Sambrook, Ilenia Simeoni, Michael Sweeting, Nicole Thornton, Sara Trompeter, Salih Tuna, Ram Varma, Matthew R. Walker, NIHR BioResource, John Danesh, David J. Roberts, Willem H. Ouwehand, Kathleen E. Stirrups, Augusto Rendon, Connie M. Westhoff, Emanuele Di Angelantonio, C. Ellen van der Schoot, William J. Astle, Nicholas A. Watkins, William J. Lane; Blood Adv 2020; 4 (15): 3495–3506. Original paper.

1. A large deletion spanning XG and GYG2 constitutes a genetic basis of the Xg_null phenotype, underlying anti‐Xg^a production. Lee, Y. Q., Storry, J. R., Karamatic Crew, V. , Halverson, G. R., Thornton, N. and Olsson, M. L.Transfusion.  2019; 59: 1843-1849. Original paper.
   
   
2. Missense mutations in the C-terminal portion of the B4GALNT2-encoded glycosyltransferase underlying the Sd(a−) phenotype. Linn Stenfelt, Åsa Hellberg, Mattias Möller, Nicole Thornton, Göran Larson, Martin L. Olsson. Biochemistry and Biophysics Reports.  2019; 19: 100659, ISSN 2405-5808. Original paper.
   
   
3. Lee Y, Storry J, Karamatic Crew V, Halverson G, Thornton N, Olsson M. A large deletion spanning XG and GYG2 constitutes a genetic basis of the Xg_null phenotype, underlying anti-Xg^a production. Vox Sang.  2019; 114 (Suppl. 1): 51. Abstract
   
   
4. Yosephi L, Karamatic Crew V, Shinar E, Zelig O, Yahalom V, Jones B, Walser P, Thornton N, Muncher L.  A Lutheran related antibody detected in a patient with a homozygous missense BCAM mutation indicating a novel antigen of the system.  Vox Sang.  2019; 114 (Suppl. 1): 52. Abstract.
   
   
5. Karamatic Crew V, Mayer B, Baglow L,Yürek S, Bartolmäs T, Walser P, Thornton N.  A novel high frequency antigen in the Lutheran blood group system (LUNU).  Vox Sang.  2019; 114 (Suppl. 1): 52. Abstract.
   
   
6. Karamatic Crew V, Jones B, McNeill A, Bruce D, Hogan A, Scott Y, Hamed M, AlRadwan R, Khrousey M, Thornton N.  Two Lan null individuals with novel ABCB6 null alleles and a compound heterozygote with a rare combination of known null and weak ABCB6 alleles.  Vox Sang.  2019; 114 (Suppl. 1): 191. Abstract.
   
   
7. Thornton N, Grimsley S.  Clinical significance of antibodies to antigens in the ABO, MNS, P1PK, Rh, Lutheran, Kell, Lewis, Duffy, Kidd, Diego, Yt, and Xg blood group systems.  Immunohematology.  2019; 35(3):95-101. Review paper.
   
   
8. Thonier, S. Cohen-Bacrie, I. Loussert, N. Thornton, R. Djoudi, G. Woimant, C. Boulat, F. Pirenne, T. Peyrard. Management of the blood supply for a Jk(a-b-) patient with an anti-Jk3 in preparation for an urgent heart transplant: An illustrative example of a successful international cooperation. Transfusion Clinique et Biologique. 2019; 26 (1): 48-55.  DOI: 10.1016/j.tracli.2018.04.002. Original paper.

1. Hawksworth J, Satchwell TJ, Meinders M, Daniels DE, Regan F, Thornton NM, Wilson MC, Dobbe JG, Streekstra GJ, Trakarnsanga K, Heesom KJ, Anstee DJ, Frayne J, Toye AM.  Enhancement of red blood cell transfusion compatibility using CRISPR-mediated erythroblast gene editing.  EMBO Mol Med. 2018 Apr 26. pii: e8454. doi: 10.15252/emmm.201708454. Original paper.
   
   
2. Win N, Needs M, Thornton N, Webster R, Chang C.  Transfusions of least-incompatible blood with intravenous immunoglobulin plus steroids cover in two patients with rare antibody.  Transfusion. 2018;58(7):1626-1630.  doi: 10.1111/trf.14648. Case report.
   
   
3. Karamatic Crew V, Laundy R, McNeill A, Jones B, Lawrence C, Davison C, Win N, Lancut J, Turnley S, Palmer D, Aszal S, Blackburn A, Mitha R, Trimble T, Walser P, Thornton N.  Serological and molecular characterisation of two novel high frequency antigens in the Yt blood group system.  Vox Sang.  2018; 113 (Suppl. 1): 63. Abstract.
   
   
4. Pelc-Kłopotowska M, Guz K, Orzińska A, Łopieńska H, Bednarz J, Mazowiecka H, Michalewska B, Uhrynowska M, Karamatic Crew V, Thornton N, Brojer E.  Antibodies against high frequency antigen detected in Polish patients between 2000 and 2017. Vox Sang.  2018; 113 (Suppl. 1): 231. Abstract.
   
   
5. Henny C, Thornton N, Lejon Crottet S, Baglow L, Graber J, Niederhauser C, Hustinx H. An antibody against a novel high incidence antigen in the Indian blood group system. Vox Sang.  2018; 113 (Suppl. 1): 231. Abstract.
   
   
6. Jones B, Karamatic Crew V, Musa R, Ahmad N, Muniandi G, Hassan A, AbuAmin N, Thornton N.  The first evidence of the KANNO− phenotype and anti-KANNO in an individual of Indian origin Vox Sang.  2018; 113 (Suppl. 1): 232. Abstract.
   
   
7. Tilley L, Laundy R, Bui T, Bach Q, Hoang T, Pham T, Nguyen A, Thornton N.  A case of anti-PP1P^k produced in a compound heterozygote with a novel A4GALT null allele. Vox Sang.  2018; 113 (Suppl. 1): 252. Abstract.
   
   
8. Thornton N.  The importance of blood groups.  Transf Med. 2018; 28 (Suppl. 1): 10. Race & Sanger Award lecture abstract.
   
   
9. Lewis S, Dzialach E, Grimsley S, Kingdom S, Bishop D, Hines A, Alderman C, Thornton N.  Identification of a novel D variant I157S in a patient with alloanti-D. Transf Med. 2018; 28 (Suppl. 1): 39. Abstract.
   
   
10. Baglow L, Laundy R, Karamatic Crew V, Eggington J , Asher O, Yahalom V, Folman C, Ligthart P, Veldhuisen B, Thornton N.  Three new unrelated examples of the rare YTEG– phenotype and anti-YTEG.  Transf Med. 2018; 28 (Suppl. 1): 40. Abstract.
    
    
11. Storry, J.R., Clausen, F.B., Castilho, L., Chen, Q., Daniels, G., Denomme, G., Flegel, W.A., Gassner, C., de Haas, M., Hyland, C., Yanli, J., Keller, M., Lomas‐Francis, C., Nogues, N., Olsson, M.L., Peyrard, T., van der Schoot, E., Tani, Y., Thornton, N., Wagner, F., Weinstock, C., Wendel, S., Westhoff, C. and Yahalom, V. (2019), International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology: Report of the Dubai, Copenhagen and Toronto meetings. Vox Sang, 114: 95-102. Working party report.

1. Ellen M. Leffler, Gavin Band, George B. J. Busby, Katja Kivinen, Quang Si Le, Geraldine M. Clarke, Kalifa A. Bojang, David J. Conway, Muminatou Jallow, Fatoumatta Sisay-Joof, Edith C. Bougouma, Valentina D. Mangano, David Modiano, Sodiomon B. Sirima, Eric Achidi, Tobias O. Apinjoh, Kevin Marsh, Carolyne M. Ndila, Norbert Peshu, Thomas N. Williams, Chris Drakeley, Alphaxard Manjurano, Hugh Reyburn, Eleanor Riley, David Kachala, Malcolm Molyneux, Vysaul Nyirongo, Terrie Taylor, Nicole Thornton, Louise Tilley, Shane Grimsley, Eleanor Drury, Jim Stalker, Victoria Cornelius, Christina Hubbart, Anna E. Jeffreys, Kate Rowlands, Kirk A. Rockett, Chris C. A. Spencer, Dominic P. Kwiatkowski, Malaria Genomic Epidemiology Network.  (2017) Resistance to malaria through structural variation of red blood cell invasion receptors. Science 10.1126/science.aam6393 (2017).  Original paper.
   
   
2. Sek-Shir Cheong, Sarah Hull, Benjamin Jones, Ravinder Chana, Nicole Thornton, Vincent Plagnol, Anthony T Moore & Alison J Hardcastle. Pleiotropic effect of a novel mutation in GCNT2 causing congenital cataract and a rare adult i blood group phenotype.  Human Genome Variation 4, Article number: 17004 (2017).  doi:10.1038/hgv.2017.4. Original paper.
   
   
3. Maguire, K., Morris, K., Quinn, M., Herron, B., Rainey, A. and Thornton, N.  A fatal case of autoanti-Wr^b causing autoagglutination of red blood cells and intravascular haemolysis. Transfusion Med. 2017; 28: 266-268. doi:10.1111/tme.12424. Letter to the editor.
   
   
4. M Pelc-Klopotowska, R Laundy, E Bus-Poniatowska, S Grimsley, A Kowalska, B Michalewska, N Thornton, E Brojer.  Hemolytic Disease of the Fetus and Newborn Caused by Anti-Be^a.  Vox Sang. 2017:  112 (suppl 1):  P-561.
   
   
5. Tay CL, Ridgwell K, Thornton N, Crew V.  CRISPR/CAS9-mediated genome editing of the immortalised BEL-A2 erythroid cell line to create ‘designer’ reagent cells.  Transf Med.  2017; 27 (suppl 2): 21-22.
   
   
6. Tilley L, Thornton N.  Extended blood group genotyping, including ABO, using next generation whole exome sequencing.  Transf Med.  2017; 27 (suppl 2): 42.
7. Laundy R, Karamatic Crew V, Davies H, Harris C, Baglow L, Walser P, Thornton N.  A novel high incidence antigen in the Yt blood group system.  Transf Med.  2017; 27 (suppl 2): 42-43.

1. Nance, S., Scharberg, E. A., Thornton, N., Yahalom, V., Sareneva, I. and Lomas-Francis, C. (2016), International rare donor panels: a review. Vox Sang, 110: 209–218. doi:10.1111/vox.12357. Review.
   
   
2. Garcia-Sanchez, F., Pardi, C., Kupatawintu, P., Thornton, N., Rodriguez, M.-A., Lucea, I., Sood, C. and Ochoa-Garay, G. (2016), Identification of new KLF1 and LU alleles during the resolution of Lutheran typing discrepancies. Transfusion, 56: 1413–1418. doi:10.1111/trf.13556. Original paper.
   
   
3. Thornton NM.  (2016) The World Health Organization International Rare Donor Panel.  Immunohematology, 32(1): 3-7. Review.
   
   
4. Thornton NM.  (2016) The United Kingdom National Rare Donor Panel.  Immunohematology, 32(2): 67-69. Review.
   
   
5. Karamatic Crew V, Laundy R, Bahashwan A, Walser P, Skidmore I, Wall L, Thornton N.  Two novel high incidence antigens in the Lutheran blood group system (LUAC and LUBI).  Vox Sang. 2016: 111 (suppl 1): 63.
   
   
6. Thornton NM.  Complex red cell antibody case analysis.  Vox Sang. 2016: 111 (suppl 1): 67.
   
   
7. Henny C, Karamatic Crew V, McNeill A, Lejon Crottet S, Niederhauser C, Braschler TR, Hustinx H, Thornton N.  A patient of caucasian origin with anti-Sc3 and the SC-null phenotype due to a novel ERMAP mutation.  Vox Sang. 2016: 111 (suppl 1): 223.
   
   
8. Karamatic Crew V, Jones B, DeSAy K, Laundy R, Walser P, Gray A, Thornton N.  Molecular characterisation of weak Lua and Lub expression associated with altered LU*01 and LU*02 alleles.  Transf Med.  2016; 26 (suppl 2): 9.
   
   
9. Laundy R, Ramos R, Shorner E, Duarte K, Cruz K, Tilley L, Thornton N.  A new example of the rare Wr(a+b-) phenotype and anti-Wrb.  Transf Med.  2016; 26 (suppl 2): 9.
   
   
10. Jones B, Joshi S, Karamatic Crew V, Sheladiya A, Mendapra K, Thornton N.  A new high incidence antigen of the Indian blood group system.  Transf Med.  2016; 26 (suppl 2): 20-21.
    
    
11. Tilley L, Thornton N.  Predicting blood group phenotypes, including Rh and MNS, from next generation exome sequencing data.  Transf Med.  2016; 26 (suppl 2): 25.
12. Storry, J.R., Castilho, L., Chen, Q., Daniels, G., Denomme, G., Flegel, W.A., Gassner, C., de Haas, M., Hyland, C., Keller, M., Lomas‐Francis, C., Moulds, J.M., Nogues, N., Olsson, M.L., Peyrard, T., van der Schoot, C.E., Tani, Y., Thornton, N., Wagner, F., Wendel, S., Westhoff, C. and Yahalom, V. (2016), International society of blood transfusion working party on red cell immunogenetics and terminology: report of the Seoul and London meetings. VOXS, 11: 118-122. Working party report.

1. Thornton, N. (2015), Serological tools for investigating immunohaematology problems. VOXS, 10: 26–30. doi:10.1111/voxs.12143. Original paper.
   
   
2. Thornton NM, Karamatic Crew V, Muniz-Diaz E, Garcia-Arroba J, Nogues N, Lee E, Jones C, Schistal E, Jungbauer C, Allhoff W, Bullock T, Marais I, Daniels G.  Four examples of anti-CD99 and discovery of the molecular bases of the rare CD99- phenotype.  Vox Sang.  2015: 109 (suppl 1): 50-51.
   
   
3. Kittivorapart JK, Karamatic Crew V, Thornton N, Daniels G.  Molecular characterisation of 18 individuals with the Lan null or weak phenotypes reveals four new ABCB6 null alleles.  Vox Sang. 2015: 109 (suppl 1): 59.
   
   
4. Lambert M, Grimsley S, O’Donghaile D, Thornton N.  The second example of alloanti-D in a weak D type 33 individual.  Vox Sang. 2015: 109 (suppl 1): 252-253.
   
   
5. Lee CY, Phillips B, Sekhar M, Thornton N, Storry JR, Win N.  Management and transfusion support for a pregnant woman with the parabombay (A_h) phenotype.  Vox Sang. 2015: 109 (suppl 1): 254.
   
   
6. Bullock T, Folmann C, van der Mark-Zoet J, Uchikawa M, Thornton N, Daniels G.  The first example of anti-KANNO found outside of Japan.  Vox Sang. 2015: 109 (suppl 1): 261.
   
   
7. Karamatic Crew V, Marais I, Thornton N, Rubbins H, Skidmore I, Daniels G.  A novel DO mutation giving rise to a Gy(a-) phenotype: a serological and molecular study.  Vox Sang. 2015: 109 (suppl 1): 279-280.
   
   
8. Lambert M, Tilley L, Ni Loingsigh S, Power J, Fitzgerald J, Thornton N.  ‘Irish’ Bonbay phenotype: compound heterozygosity for novel FUT1 alelles.  Vox Sang. 2015: 109 (suppl 1): 280.
   
   
9. Tilley L, McNeill A, Moser MI, Romeiras MC, Thornton N, Daniels G.  A novel SEMA7A allele in a compound heterozygote, resulting in variant JMH expression and alloanti-JMH production.  Vox Sang. 2015: 109 (suppl 1): 283.
   
   
10. Tilley L, McNeill A, Eggington J, Martin P, Thornton N, Daniels G.  A novel mutation in FY*A resulting in aberrant expression of Duffy antigens.  Vox Sang. 2015: 109 (suppl 1): 297-298.

1. Seltsam A, Wagner F, Lambert M, Bullock T, Thornton N, Scharberg EA, Grueger D, Schneeweiss C and Blasczyk R.  Recombinant blood group proteins facilitate the detection of alloantibodies to high-prevalence antigens and reveal underlying antibodies: results of an international study.  Transfusion. Article first published online: 18 MAR 2014, DOI: 10.1111/trf.12553. Original paper.
   
   
2. Thornton NM.  Serological tools for investigating immunohaematology problems.  Vox Sang. 2014: 107 (suppl 1): 3.
   
   
3. Sookraj A, Olsen CN, Thornton N, Reddy PA, Juganath N, Amra S, MacLaren G.  Anti-Lan case study: International collaboration improves prognosis of patient.  Vox Sang. 2014: 107 (suppl 1): 103.
   
   
4. Hustinx H, Lejon-Crottet S, Henny C, Niederhauser C, Karamatic Crew V, Bullock T, Burton N, Thornton N.  LUIT: a novel high incidence antigen in the Lutheran blood group system.  Vox Sang.  2014: 107 (suppl 1): 172.
   
   
5. Arsenovic MG, Grimsley S, Sorvoll IH, McNeil A, Titze TL, Husebekk, Olsson ML, Thornton N, Storry JR.  The Rh_null phenotype in a Norwegian family is due to a novel RHAG mutation.  Vox Sang.  2014: 107 (suppl 1): 192.
   
   
6. McNeil A, Grimsley S, DeSay K, Liew Y-W, Tong C-Y, Tsoi W-C, Thornton N, Daniels G.  A rare cD-/(C)D- phenotype in an individual and production of anti-Rh17-like.  Transf Med.  2014; 24 (suppl 2): 26.
   
   
7. Karamatic-Crew V, Thornton N, McNeill A, Ines Moser M, Rodrigues M, Pimental R, Daniels G.  A novel molecular background and a family study of a Gy(A-) individual with anti-Gy^a.  Transf Med.  2014; 24 (suppl 2): 26-27.
   
   
8. Grimsley S, Bullock T, Search S, McNeill A, Marais I, DeSay K, Thornton N, Daniels G.  An individual with the R2R0Har phenotype was positive with three monoclonal anti-e and produced alloanti-e.  Transf Med.  2014; 24 (suppl 2): 27.
   
   
9. Tilley L, Laundy R, van der Mark-Zoet J, Folman C, de Haas M, Thornton N, Daniels G.  Homozygosity for a variant SEMA7A allele resulting in loss of a novel high frequency JMH antigen.  Transf Med.  2014; 24 (suppl 2): 27-28.
   
   
10. McNeill A, Crew V, Sowinski K, Daley J, Curtin J, Bruce H, Hull S, Parsons K, Thornton N.  A new example of haemolytic disease of the newborn caused by anti-VONG.  Transf Med.  2014; 24 (suppl 2): 74.

1. Thornton N.  Characteristics and serologic determination of antibodies to high frequency antigens. Vox Sang.  2013; 105 (suppl 1): 2.
   
   
2. Varamatic-Crew V, Thornton N, Bullock T, Muniz-Diaz E, Castella M, Nogues N, Daniels G.  Serological and molecular characterisation of DOLC, a novel high incidence antigen in the Dombrock blood group system.  Vox Sang.  2013: 105 (suppl 1): 30.
   
   
3. Eggington J, Grimsley S, Nawrocki A, Tilley L, Thornton N, Daniels G.  Anti _D in pregnancy with the novel RHD*IVS6+1G>T DEL phenotype.  Transf Med.  2013; 23 (suppl 2): 60.
   
   
4. Tilley L, Grimsley S, McNeil A, Cahill M, Reid H, Reardon E, Moore N, Thornton N, Daniels G.  Three novel RHD alleles resulting in D variant phenotypes.  Transf Med.  2013; 23 (suppl 2): 63.
   
   
5. Thornton N, Karamatic-Crew V, Liew Y-W, Guthrie K, Daniels G.  A new example of the rare UMC- phenotype.  Transf Med.  2103: 23 (suppl 2): 65.
   
   
6. Grimsley S, Skidmore I, Lee E, Thornton N, Daniels G.  Two novel RhD variants that share the weak D type 4 mutations.  Transf Med.  2013; 23 (suppl 2): 65.
   
   
7. Scally E, Karamatic-Crew V, Green C, Thornton N, Daniels G.  Molecular characterisation of six Jr(a-) individuals reveals four new ABCG2 null alleles.  Transf Med.  2013; 23 (suppl 2): 65-66.
   
   
8. Karamatic-Crew V, Thornton N, Mathlouthi R, Macek Kvanka M, Urbas M, Daniels G.  A family study and a novel molecular background of a Gy(a-) individual with anti-Gy^a.  Transf Med.  2013; 23 (suppl 2): 66.
   
   
9. Lambert M, Grimsley S, Adshead A, Thornton N, Daniels G, Fitzgerald J.  Weak D type 10: A ‘common’ weak D type in Ireland, typing as RhD negative in donors?  Transf Med.  2013; 23 (suppl 2): 66.
   
   
10. Wagner M, van Dunne F, Kuipers I, Thornton N, Folman C, Ponjee E, Oepkes D.  Anti-Emm in a pregnant patient – case report.  Vox Sang.  2013; published online 25 Oct 2013, DOI: 10.1111/vox.12104. Original paper.

1. Flatt JF, Musa RH, Ayob Y, Hassan A, Asidin N, Yahya NM, Mathlouthi R, Thornton N, Anstee DJ, Bruce LJ. Study of the D-- phenotype reveals erythrocyte membrane alterations in the absence of RHCE.  Br J Haematol. 2012;158(2):262-73. Original paper.

2010

1. Mayer B, Thornton N, Yürek S, Wylie D, Hue-Roye K, Poole J, Bartolmäs T, Salama A, Lomas-Francis C, Velliquette RW, Yazdanbakhsh K, Reid ME. New antigen in the Dombrock blood group system, DOYA, ablates expression of Do(a) and weakens expression of Hy, Jo(a), and Gy(a) antigens. Transfusion. 2010 Jun;50(6):1295-302. Epub 2010 Jan 15. Original paper.
   
   
2. Stamps, J. Poole, T. Bullock, N. Thornton, V. Crew, H. Kilgallon. A rare finding of an auto-antibody showing Lutheran specificity. Transf Med 2010; 20 suppl. 1: 11.
   
   
3. Karamatic Crew, J. Poole, N. Thornton, T. Bullock, C. Fernandez-Alvarez, A. Davis, G. Daniels. Two unusual cases within the Cromer blood group system I) A novel high incidence antigen Croz and II) A novel molecular basis of Inab phenotype. Transf Med 2010; 20 suppl. 1: 12.
   
   
4. Poole J, Thornton NM, Tilley L, Lambert M, Fitzgerald J, Mulvanny L, Brassil M, Daniels G.  Novel high incidence antigen in the Diego blood group system (DISK) and clinical significance of anti-DISK.  Vox Sang 2010; 99(suppl 1):30.

2009

1. Crew VK, Thornton N, Burton N, Poole J, Search S, Daniels G
   Two heterozygous mutations in an individual result in the loss of a novel high-incidence Lutheran antigen LURC.  Transf Med 2009;19 suppl. 1: 10.

2008

1. Flatt JF, Poole J, Warke N, Morris K, Arrizabalaga B, Bruce LJ 
   Study of Rhnull: Carbon dioxide transport properties and the importance of RhAG in the band 3 macrocomplex.  Transf Med 18:17 2008.
   
   
2. Crew VK, Poole J, Long S, Warke N, Colavecchia C, Burton N, Moulds M, Schlanser G, Wilson L, Noumsi G, Moulds JM, Moulds JJ, Daniels G. Two MER2-negative individuals with the same novel CD151 mutation and evidence for clinical significance of anti-MER2.  Transfusion. 48(9):1912-6 (2008). Original paper.
   
   
3. Warke N, Poole J, Mayer B, Bartomaes T, Yurek S, Hue-Roye K, Lomas-Francis C, Reid ME;  New antigen in the Dombrock blood group system: DOYA.  Transfusion  2008; 48(Suppl.): 209A.

2007

1. Poole J, Tilley L, Warke N, Spring FA, Overbeeke MA, van der Mark-Zoet JA, Ahrens N, Armstrong D, Williams M, Daniels G. Two missense mutations in the CD44 gene encode two new antigens of the Indian blood group system. Transfusion. 2007 Jul;47(7):1306-11. Original paper.
   
   
2. Lee E, Malde R, Redman M, Warke N, Nulty H.  Transient Suppression of the AnWj Antigen in a Post-BMT Patient.  Transf Med 2007; 17: Suppl 1 P10.
   
   
3. Needs M, Poole J, Warke N, De Lord C, MacRate E, Win N.  A Case of Anti-Era in Pregnancy.  Transf Med 2007; 17: Suppl 1 P19.

2006

1. Warke N.  The Use of the MAIEA Assay for Solving Serological Problems and Identifying Novel Blood Group Antigens.  Transf Med 2006; 16: Suppl 1 YS06.
   
   
2. Karamatic Crew V, Warke N, Ahrens N, Poole J, Daniels G.  The Second Example of LU:-4: a Serological and Molecular Study.  Transf Med 2006; 16: Suppl 1 P39.

2005

1. Poole J, Tilley L, Warke N, Banks J, Ahrens N.  Molecular Basis of Two Novel High Incidence Antigens on CD44 (Indian Blood Group System).  Transf Med 2005; 15: Suppl 1 SI45.
   
   
2. Poole J, Warke N, King M-J, Bishop D, Search S.  An Antibody to a Novel Glycophorin B Epitope Made in a GP.Mur/GP.Mur (MiIII/MiIII) Individual.  Transf Med 2005; 15: Suppl 1 SI46.
   
   
3. Mathie M, Warke N, McQuade M, Poole J.  An Rh Autoantibody with Rh51 Specificity.  Transf Med 2005; 15: Suppl 1 P39.

2004

1. Banks J, Poole J, Prowse C, Warke N, Ekermo B, Hilden J-O.  Transient loss of Cromer antigens and anti-IFC in a patient with chronic lymphatic leukaemia.  Vox Sanguinis 2004; 87: Suppl 3 P17.3.

2003

1. Irwin K, Melanaphy R, Warke N, Nascimento, Banks J, Martin P, Chabert T, Rodrigues MJ, Morris K, Poole J. A new Rh_null blood donor and the International Rare Donor Panel. Transf Med 13 supp. 1, P25 (2003).
   
   
2. Poole J, Morris K, Anderson J, Warke N, Melanaphy R, Jackson M. Drug induced autoimmune haemolytic anaemia in association with Mefloquine anti-malarial prophylaxis. Proceedings of VIII European Congress of the ISBT, P375 Istanbul–Turkey July 5-9 (2003).
   
   
3. Poole J, Warke N, Melanaphy R, Murdock J, Anderson J, Jackson M and Morris K. Drug-Induced AIHA in Association with Mefloquine Antimalarial Prophylaxis. Transf Med 13 supp.1. O11 (2003).

2002

1. Poole J, Hustinx H, Warke N, Crew V, Martin P, Daniels G. A new allele of the KEL gene. Transf Med 2002; 12: Suppl 1 O1.
   
   
2. Warke N, Skidmore I, Poole J. Use of the MAIEA assay in the red cell reference laboratory. Transf Med 2002; 12: Suppl 1 P24.

2001

1. Poole J, Daniels G, Hustinx H, Martin P, Green CA, Warke N, Bromilow I. A novel K allele of the KEL gene. Transfusion 2001;41(suppl):15S.
   
   
2. Poole J, Warke N, Shepherd D, Hall C. A C typing problem and observations on the r’’G phenotype. Transf Med 11 suppl 1;32, 2001.
   
   
3. Warke N Serological Complexities of Rh: a 17-month study. Transf Med 11 suppl. 1:7, 2001. YS5.

1. Recommendation for validation and quality assurance of non-invasive prenatal testing for foetal blood groups and implications for IVD risk classification according to EU regulations.

   Clausen FB, Hellberg Å, Bein G, Bugert P, Schwartz D, Drnovsek TD, Finning K, Guz K, Haimila K, Henny C, O'Brien H, Orzinska A, Sørensen K, Thorlacius S, Wikman A, Denomme GA, Flegel WA, Gassner C, de Haas M, Hyland C, Ji Y, Lane WJ, Nogués N, Olsson ML, Peyrard T, van der Schoot CE, Weinstock C, Legler T.

   Vox Sang. 2021 Jun 21. doi: 10.1111/vox.13172. Online ahead of print.

   PMID: 34155647 Review. 

1. Diagnostic accuracy of routine antenatal determination of fetal RHD status across gestation: population based cohort study

   Lyn S Chitty,,Kirstin Finning, Angela Wade, Peter Soothill, Bill Martin, Kerry Oxenford, Geoff Daniels, Edwin Massey.

   British Medical Journal. 2014 September.
   
   

2. Use of cffDNA to avoid administration of anti-D to pregnant women when the fetus is RhD-negative: implementation in the NHS
   
   PW Soothill,K Finning,T Latham,T Wreford-Bush,J Ford,G Daniels

   International journal of Obstetrics & Gynaecology. 2014 August.

1. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service

   K.M. Finning, P.G. Martin, P.W. Soothill, N.D. Avent

   Transfusion. 2002 August.

1. Reyland L, Green F, Ridgwell K, Hunter R, Dempsey-Hibbert N (2021) Optimisation of a flow cytometric method for fetomaternal haemorrhage estimation using anti-fetal haemoglobin (anti-HbF). BBTS ASM (Poster).
   
   
2. Gulaid. K, Dixey J. Guest. A, Hazell M (2021) The Potential for Anti-CD47 Fab Fragments to Inhibit the Interference of Therapeutic Anti-CD47 in Serological Investigations. BBTS ASM (Poster).
   
   
3. Lees R,  Ward D, Mushens R, Burden M, Blair D, Mullin A, Williams M (2021) The development, validation and implementation of IgA deficiency and anti-IgA testing by flow cytometry in NHS Blood and Transplant. BBTS ASM (Poster).

1. Legge DN, Chambers AC, Parker CT, Timms P, Collard TJ, Williams AC (2020) The role of B-Cell Lymphoma-3 (BCL-3) in enabling the hallmarks of cancer: implications for the treatment of colorectal carcinogenesis. Carcinogenesis 41(3):249-56.

1. Smethurst PA, Jolley J, Braund R, Proffitt S, Lynes T, Hazell M, Mellor P, Ridgwell K, Procter S, Griffiths A, Marinaki AM, New HV, Murphy GJ, Edmondson D, Cardigan R, REDJUVENATE Trial Investigators (2019) Rejuvenation of RBCs: validation of a manufacturing method suitable for clinical use. Transfusion 59(9):2952-2963.
   
   
2. Poles A, Lucas G, Green F, Walser P, Davey S, Ridgwell K, Wylie P (2019). Neonatal alloimmune thrombocytopenia due to a new alloantigen (Bla) defined by an Asp458Gly substitution in GPIIIa. Transfusion 59:396-404.

1. Hunter RW, Hughey CC, Lantier L, Sundelin EI, Peggie M, Zeqiraj E, et al. (2018) Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase. Nat Med. 24(9):1395-1406.
   
   
2. Green F, Lewis R, Ridgwell K (2018). Soluble recombinant CD38 inhibition of therapeutic anti-CD38 monoclonal antibodies in patient samples: facilitating serological investigation and improving patient care. BBTS ASM (Poster).
   
   
3. Stanton A, Sacco P, Hopkins M, Besant C, Horler J, Green F, Poles A (2018). The incidence of detectable HPA-1a antibodies in UK NAIT referrals. A single centre evaluation. BSHI Annual Conference (Oral presentation).
   
   
4. Green F, Ridgwell K, Johnson J, Riel A, Poles A (2018). Evaluation of an in-house assay for TRALI reduction using Luminex beads coupled to soluble recombinant HNA proteins. European Symposium on Platelet and Granulocyte Immunology (Poster).
   
   
5. Johnson J, Green F, Poles A (2018). Comparison of HNA antibody screening assays for the detection of HNA-3 antibodies. BSHI Annual Conference (Poster).
   
   
6. Poles A, Lucas G, Green F, Walser P, Davey S, Ridgwell K (2018). Neonatal alloimmunethrombocytopenia due to a new alloantigen Bl(a) defined by an Asp458Gly substitution in GPIIIa. ESPGI (Poster).
   
   
7. Singleton BK, Ahmed M, Green CA, Heimpel H, Woźniak MJ, Ranjha L, Seeney F, Bomford A, Mehta P, Guest A, Mushens R, King M-J (2018). CD44 as a potential screening marker for preliminary differentiation between Congenital Dyserythropoietic Anemia Type II and Hereditary Spherocytosis. Cytometry B Clin Cytom. 94:312-326.

1. Hopkins M, Lucas G, Calvert A, Bendukidze N, Green F, Poles A (2017). Human platelet antigen (HPA)‐specific immunoglobulin M antibodies in neonatal alloimmune thrombocytopenia can inhibit the binding of HPA‐specific immunoglobulin G antibodies. Transfusion 57:1267–1271.

1. Bullock T, Bruce LJ, Ridgwell K (2016). Current topics in red cell biology: report on the Red Cell Special Interest Group meeting held at NHS Blood and Transplant Bristol on 30 October 2015. Transfusion Med. 26:241-245.
   
   
2. Carter JL, Parker CT, Stevens PE, Eaglestone G, Knight S, Farmer CK, Lamb EJ (2016) Biological variation of plasma and urinary markers of acute kidney injury in patients with chronic kidney disease. Clinical chemistry 1;62(6):876-83.
   
   
3. Imoh LC, Mutale M, Parker CT, Erasmus RT, Zemlin AE (2016) Laboratory-based clinical audit as a tool for continual improvement: an example from CSF chemistry turnaround time audit in a South-African teaching hospital. Biochemia medica 15;26(2):194-201.

1. Shehata SN, Deak M, Morrice NA, Ohta E, Hunter RW, Kalscheuer VM, et al. Cyclin Y phosphorylation- and 14-3-3-binding-dependent activation of PCTAIRE-1/CDK16. Biochem J. 2015;469(3):409-20.
   
   
2. Green F, Ridsdale C, Gilbert J, Ridgwell K, Curnow E, Bruce D (2015). Comparison of Quantitation, Titre scores and Flow cytometry for the estimation of maternal Anti-D and anti-c. Joint ISBT/BBTS ASM (Poster).
   
   
3. Chong W, Turro E, Metcalfe P, Yusuf R, Mérieux Y, Rigal D, Porcelijn L, Huiskes E, Lucas G, Bendukidze N, Green A, Fontão-Wendel R, Husebekk A, Dixey J, Guest A, Mushens R, Ouwehand WH, Navarrete CV (2015). A multicenter validation of recombinant β3 integrin-coupled beads to detect human platelet antigen-1 alloantibodies in 498 cases of fetomaternal alloimmune thrombocytopenia. Transfusion 55:2742-51.

1. Kumpel B, Hazell M, Guest A, Dixey J, Mushens R, Wreford-Bush T, Bishop B, Lee E (2014). Accurate quantitation of D-positive fetomaternal hemorrhage by flow cytometry using a novel reagent to eliminate granulocytes from analysis. Transfusion 54:1305-16.
   
   
2. Zeqiraj E, Tang X, Hunter RW, Garcia-Rocha M, Judd A, Deak M, et al. Structural basis for the recruitment of glycogen synthase by glycogenin. Proc Natl Acad Sci U S A. 2014;111(28): E2831-40.
   
   
3. Onselaer MB, Oury C, Hunter RW, Eeckhoudt S, Barile N, Lecut C, et al. The Ca(2+) /calmodulin-dependent kinase kinase beta-AMP-activated protein kinase-alpha1 pathway regulates phosphorylation of cytoskeletal targets in thrombin-stimulated human platelets. J Thromb Haemost. 2014;12(6):973-86.
   
   
4. Moore SF, Hunter RW, Hers I. Protein kinase C and P2Y12 take center stage in thrombin-mediated activation of mammalian target of rapamycin complex 1 in human platelets. J Thromb Haemost. 2014;12(5):748-60.
   
   
5. Kim M, Hunter RW, Garcia-Menendez L, Gong G, Yang YY, Kolwicz SC, Jr., et al. Mutation in the gamma2-subunit of AMP-activated protein kinase stimulates cardiomyocyte proliferation and hypertrophy independent of glycogen storage. Circ Res. 2014;114(6):966-75.
   
   
6. Hunter RW, Zeqiraj E, Morrice N, Sicheri F, Sakamoto K. Expression and purification of functional human glycogen synthase-1: glycogenin-1 complex in insect cells. Protein Expr Purif. 2014;108:23-9.
   
   
7. Hunter RW, Foretz M, Bultot L, Fullerton MD, Deak M, Ross FA, et al. Mechanism of action of compound-13: an alpha1-selective small molecule activator of AMPK. Nat Chem Biol. 2014;21(7):866-79.
   
   
8. Green F, Ridgwell K (2014). Availability of Blood for Genotyped Patients. BBTS ASM (Poster).

1. Bell AJ, Satchwell TJ, Heesom KJ, Hawley BR, Kupzig S, Hazell M, Mushens R, Herman A and Toye AM (2013). Protein Distribution during Human Erythroblast Enucleation In Vitro. PLoS ONE 8: 1-12.
   
   
2. Poles A, Wozniak MJ, Walser P, Ridgwell K, Fitzgerald J, Green A, Gilmore R, Lucas G (2013). A V740L mutation in glycoprotein IIb defines a novel epitope (War) associated with fetomaternal alloimmune thrombocytopenia. Transfusion 53:1965-73.
   
   
3. Lucas G, Porcelijn L, Fung YL, Green F, Reil A, Hopkins M, Schuller R, Green A, de Haas M, Bux J (2013). External quality assessment of human neutrophil antigen (HNA)-specific antibody detection and HNA genotyping from 2000 to 2012. Vox Sang. 105:259-69.
   
   
4. Wan M, Leavens KF, Hunter RW, Koren S, von Wilamowitz-Moellendorff A, Lu M, et al. A noncanonical, GSK3-independent pathway controls postprandial hepatic glycogen deposition. Cell Metab. 2013;18(1):99-105.
   
   
5. von Wilamowitz-Moellendorff A, Hunter RW, Garcia-Rocha M, Kang L, Lopez-Soldado I, Lantier L, et al. Glucose-6-phosphate-mediated activation of liver glycogen synthase plays a key role in hepatic glycogen synthesis. Diabetes. 2013;62(12):4070-82.
   
   
6. Green F, Karamatic Crew V, Green C, Ridgwell K, Burton N, Daniels G (2013). The use of KEL constructs expressed in HEK293 cells to investigate antibody reactions to Kell variants. BBTS ASM (Poster).
   
   
7. Jeppesen J, Maarbjerg SJ, Jordy AB, Fritzen AM, Pehmoller C, Sylow L, Hunter R, et al. LKB1 regulates lipid oxidation during exercise independently of AMPK. Diabetes. 2013;62(5):1490-9.

1. Kumpel B, Hazell M, Guest A, Dixey J, Mushens R (2012). Improved flow cytometric quantification of D+ RBC in Fetomaternal Hemorrhage (FMH) samples by the elimination of neutrophils from analysis. AABB (Poster).
   
   
2. Kumpel B, Hazell M, Guest A, Mushens R (2012). A novel reagent for rapid and accurate fetomaternal haemorrhage quantitation by flow cyrometry that eliminates leucocytes from analysis. Transfusion Medicine 22(suppl.1): 22.
   
   
3. Moore SF, van den Bosch MT, Hunter RW, Sakamoto K, Poole AW, Hers I. Dual regulation of glycogen synthase kinase 3 (GSK3) alpha/beta by protein kinase C (PKC)alpha and Akt promotes thrombin-mediated integrin alphaIIbbeta3 activation and granule secretion in platelets. J Biol Chem. 2012;288(6):3918-28.
   
   
4. Moore SF, Hunter RW, Harper MT, Savage JS, Siddiq S, Westbury SK, et al. Dysfunction of the PI3 kinase/Rap1/integrin alpha(IIb) beta(3) pathway underlies ex vivo platelet hypoactivity in essential thrombocythemia. Blood. 2012;121(7):1209-19.
   
   
5. Kumpel B, Hazell M, Guest A, Mushens R (2012). A novel reagent for rapid and accurate fetomaternal haemorrhage quantitation by flow cytometry that eliminates leucocytes from analysis. BBTS ASM (Poster).
   
   
6. Green F, Ridgwell K (2012). Quantitation of anti-D and anti-c antibody levels by flow cytometry. NHSBT R&D Annual Conference (Poster).
   
   
7. Green F, Ridgwell K (2012). Revisiting anti-D and anti-c quantification by flow cytometry. Quantification User Group Meeting, Birmingham (Oral presentation).
   
   
8. Green F, Ridgwell K (2012). Anti-D and anti-c quantification by flow cytometry. SIG Session: Blood Bank Technology. BBTS ASM (Oral presentation).

1. Allen D, Abrahamson S, Murphy MF, Roberts DJ (2011). Human Platelet Antigen 1a epitopes are dependent on the cation-regulated conformation of integrin GPIIb/IIIa (αIIbβ3). J Immunol Methods 31:166-75. Acknowledgement.
   
   
2. Chong W, Metcalfe P, Mushens R, Lucas G, Ouwehand WH, Navarrete CV (2011). Detection of human platelet antigen-1a alloantibodies in cases of fetomaternal alloimmune thrombocytopenia using recombinant β3 integrin fragments coupled to fluorescently labelled beads. Transfusion 51: 1261-1270.
   
   
3. King M-J, Jepson M.A, Guest A, Mushens R (2011). Detection of hereditary pyropoikilocytosis by the eosin-5-maleimide (EMA) binding test is attributable to a marked reduction of EMA-reactive transmembrane proteins. Int. J. Lab. Hematol. 33: 205-211.
   
   
4. Wozniak M, Lucas G, Bowring C, Ridgwell K (2011). Detection of HNA-3a and -3b antibodies using transfected cell lines and recombinant proteins. Transfusion 52:1458-67.
   
   
5. Satchwell TJ, van den Akker E, Ridgwell K, Daniels G, Anstee D and Toye AM (2011). Critical band 3 multiprotein complex interactions establish early during erythropoiesis. Blood 118: 182-191.
   
   
6. Moore SF, Hunter RW, Hers I. mTORC2 protein complex-mediated Akt (Protein Kinase B) Serine 473 Phosphorylation is not required for Akt1 activity in human platelets [corrected]. J Biol Chem. 2011;286(28):24553-60.
   
   
7. Hunter RW, Treebak JT, Wojtaszewski JF, Sakamoto K. Molecular mechanism by which AMP-activated protein kinase activation promotes glycogen accumulation in muscle. Diabetes. 2011;60(3):766-74.

1. Tilley L, Green C, Poole J, Gaskell A, Ridgwell K, Burton NM, Uchikawa M, Tsuneyama H, Ogasawara K, Akkøk CA, Daniels G (2010). A new blood group system, RHAG: three antigens resulting from amino acid substitutions in the Rh-associated glycoprotein. Vox Sang. 98:151-9.
   
   
2. Lucas G, Culliford S, Green F, Sidra G, Calvert A, Green A, Harrison P, Harvey J, Allen D, Smillie D, Masurekar A, Marks D, Russell N, Massey E (2010). Recipient-derived HPA-1a antibodies: a cause of prolonged thrombocytopenia after unrelated donor stem cell transplantation. Transfusion 50:334-9.
   
   
3. Lucas G, Calvert A, Green F, Ranasinghe E, Roberts D, Sadani D, Green A (2010).
   Clinical outcomes of intrauterine platelet transfusions in fetomaternal alloimmune thrombocytopenia (FMAIT) in England. 10th European Conference on Platelet, Granulocyte and Red Cell Immunobiology.
   
   
4. Bouskila M, Hunter RW, Ibrahim AF, Delattre L, Peggie M, van Diepen JA, et al. Allosteric regulation of glycogen synthase controls glycogen synthesis in muscle. Cell Metab. 2010;12(5):456-66.
   
   
5. Green F, Armstrong D, Carter L, Lee E, Knowles R, Maley M, Tunnard V, Etheridge W (2010). Rationalisation of the investigation of autoimmune cases in RCI.
   BBTS ASM (Poster).

2009

1. Beel K, Cotter MM, Blatny J, Bond J, Lucas G, Green F, Vanduppen V, Leung DW, Rooney S, Smith OP, Rosen MK, Vandenberghe PA (2009). Large kindred with X-linked neutropenia with an I294T mutation of the Wiskott-Aldrich syndrome gene. Br J Haematol. 144:120-6.
   
   
2. Hunter RW, Mackintosh C, Hers I. Protein kinase C-mediated phosphorylation and activation of PDE3A regulate cAMP levels in human platelets. J Biol Chem. 2009;284(18):12339-48.
   
   
3. Hunter RW, Hers I. Insulin/IGF-1 hybrid receptor expression on human platelets: consequences for the effect of insulin on platelet function. J Thromb Haemost. 2009;7(12):2123-30.
   
   
4. Green F (2009) Investigation of positive DATs – the Filton Experience. NHSBT RCI Annual Scientific Meeting (Oral presentation).
   
   
5. Davies LE (2009). Characterisation of the migration of neuroblasts during formation of the Cranial Sensory Ganglia. The 18th CDB Meeting, Common Themes and New Concepts in Sensory Formation (Poster).

2008

1. Hunter RW, Harper MT, Hers I. The PKB inhibitor Akti-1/2 potentiates PAR-1-mediated platelet function independently of its ability to block PKB. J Thromb Haemost. 2008;6(11):1923-32.

2007

1. Ridgwell K, Dixey J, Scott ML (2007). Production of soluble recombinant proteins with Kell, Duffy and Lutheran blood group antigen activity, and their use in screening human sera for Kell, Duffy and Lutheran antibodies. Transfusion Medicine 17:384-394.
   
   
2. Campbell K, Rishi K, Howkins G, Gilby D, Mushens R, Ghevaert C, Metcalfe P, Ouwehand WH, Lucas G (2007). A modified rapid monoclonal antibody-specific immobilization of platelet antigen assay for the detection of human platelet antigen (HPA) antibodies: a multicentre evaluation. Vox Sang. 93:289-297.

2006

1. Armour KL, Parry-Jones DR, Beharry N, Ballinger JR, Mushens R, Williams K, Beatty C, Stanworth S, Lloyd-Evans P, Scott M, Clark MR, A. Peters M, Williamson LM (2006). Intravascular survival of red cells coated with a mutated human anti-D antibody engineered to lack destructive activity. Blood 107:2619 - 2626.
   
   
2. Lucas G, Massey E, Culliford S, Calvert A, Green F, Allen D, Marks D, Green A (2006). Megakaryocyte hypoplasia and platelet refractoriness due to GPA-1a antibodies following unrelated donor stem cell transplantation. BSHI Annual Conference (Poster).
   
   
3. Evans RG, Green FA, Lucas GF (2006). A review of referrals for neonatal alloimmune neutropenia over a 4-year period (2002-2006). Vox Sang. 91:5.
   
   
4. Massey E, Poles A, Green F, Calvert A, Lucas G, Green A (2006). Applying strict clinical and immunological criteria to the diagnosis of TRALI: the experience of a regional transfusion centre. Vox Sang. 91:9.
   

2005

1. Green FA, Lucas GF (2005). Detection of HNA-3a antibodies: A comparison of the granulocyte agglutination test and granulocyte chemiluminescence test. Transfusion Medicine 15(Suppl.1): P57.
   
   
2. Lucas GF, Green FA, Rao, K, Amrolia P, Veys P (2005). HNA-1a alloantibodies following allogeneic bone marrow transplant. Transfusion Medicine 15(Suppl.1): P57.
   
   
3. Green FA, Massey EJ, Lucas GF (2005). Enhanced detection of human neutrophil antigen (HNA) specific antibodies using two screening techniques. Br J Haematol. 129 (Suppl.1):41-42.
   
   
4. Green F, Massey EJ, Lucas GF (2005). Enhanced detection of human neutrophil antigen (HNA) specific antibodies using two screening techniques. BBTS ASM (co-author Oral presentation).

2004

1. Ridgwell K (2004) Genetics tools: PCR and sequencing. Vox Sang. 87 Suppl.1:6-12.
   
   
2. King M-J, Smythe J, Mushens R (2004). Eosin-5-maleimide binding to band 3 and Rh-related proteins forms the basis of screening test for hereditary spherocytosis. Br J Haematol. 124:106-113.
   
   
3. Campbell K, Mushens R, Lucas G, Ouwehand WH (2004). Selection of optimal glycoprotein capture antibodies in a rapid monoclonal antibody immobilisation of platelet antigens (MAIPA) assay. Platelets 15:236 (Abstract).
   
   
4. Woolard J, Wang WY, Bevan HS, Qiu Y, Morbidelli L, Pritchard-Jones RO, Cui TG, Sugiono M, Waine E, Perrin R, Foster R, Digby-Bell J, Shields JD, Whittles CE, Mushens RE, Gillatt DA, Ziche M, Harper SJ, Bates DO (2004). VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res. 64:7822-35.
   
   
5. Brown M, Bicknell R, Hart I, Mushens R (2004). Abstracts of the 41st meeting of the British Microcirculation Society. Microcirculation. 11:527-58.
   
   
6. Qiu Y, Perrin RM, Woolard J, Cui T-G, Mushens R, Harper SJ, Bates DO (2004). PC34 antibodies specific to the c terminus of VEGF165b detect protein in normal human plasma. 41st meeting of the British Microcirculation Society. Microcirculation. 11:527-58. (Abstract.).
   
   
7. Green F, Lucas G (2004). Comparison of the granulocyte chemiluminescence test with the granulocyte agglutination test. Platelets 15:243.
   

2003

1. White AR, Enever P, Tayebi M, Mushens R, Linehan J, Brandner S, Anstee D, Collinge J, Hawke S (2003). Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 422:80-3.
   
   
2. Bakacs T, Szabo M, Varga L, Mushens R, Mehrishi JN, Lutz HU, Merry AH, Tusnady G (2003). Micromolar A and B blood group active trisaccharides abolish human complement haemolytic activity assayed by erythrocytes. Int Arch Allergy Immunol. 130:236-246.
   
   
3. Korandowych E, Dixey J, Cox B, Jones S, McHugh N (2003). The Influence of the HLA-DRB1 rheumatoid arthritis shared epitope on the clinical characteristics and radiological outcome of psoriatic arthritis. J Rheumatol. 30:96-101.

2002

1. Green FA, Lucas GF (2002). Comparison of the Granulocyte Chemiluminescence Test with the Granulocyte Agglutination Test. 7th European Conference on Platelet, Granulocyte and Red Cell Immunobiology (Oral presentation).
   
   
2. Green F (2002). Blood grouping by molecular genetics – platelets and granulocytes. Transfusion Med. 12 (suppl.1):11 (Oral presentation).
   
   
3. Wallis JP, Haynes S, Stark G, Green F, Lucas G, Chapman C (2002). Transfusion related alloimmune neutropenia (TRAIN), a previously undescribed complication of blood transfusion. Lancet 360:1073.
   
   
4. Green F, Lucas G, Haynes S, Stark G, Chapman C, Wallis JP (2002). Transfusion related alloimmune neutropenia (TRAIN), a previously undescribed complication of blood transfusion caused by HNA-1b antibodies. 7th European Conference on Platelet, Granulocyte and Red Cell, Immunobiology.
   
   
5. Al-Heresh AM, Proctor J, Jones SM, Dixey J, Cox B, Welsh K, McHugh N (2002). Tumour necrosis factor-alpha polymorphism and the HLA-Cw*0602 allele in psoriatic arthritis. Rheumatology 41:525-30.

1999

1. Bruce LJ, Ring SM, Ridgwell K, Reardon DM, Seymour CA, Van Dort HM, Low PS, Tanner MJ (1999). South-east asian ovalocytic (SAO) erythrocytes have a cold sensitive cation leak: implications for in vitro studies on stored SAO red cells. Biochim Biophys Acta. 1416:258-70.
   
   
2. Lloyd-Evans P, Guest AR, Austin EB, Scott ML (1999) Use of a phycoerythrin-conjugated anti-glycophorin A monoclonal antibody as a double label to improve the accuracy of FMH quantification by flow cytometry. Transfus Med. Jun;9(2):155-60.
   
   
3. Lloyd-Evans P, Guest AR, Voak D, Scott ML (1999). Detection of weak D and D(VI) red cells in D-negative mixtures by flow cytometry: implications for feto-maternal haemorrhage quantification and D typing policies for newborns. Br J Haematol. 104:621-5.

1997

1. Jones SM, Dixey J, Hall ND, McHugh N (1997). Tumour necrosis factor-alpha polymorphism and the HLA-Cw*0602 allele in psoriatic arthritis. Br J Rheumatology 36:748-57.

1996

1. Avent ND, Liu W, Warner KM, Mawby WJ, Jones JW, Ridgwell K, Tanner MJ (1996). Immunochemical analysis of the human erythrocyte Rh polypeptides. J Biol Chem. 14; 271:14233-9.
   
   
2. Mushens R.E, Guest AR, Scott ML, Voak D, Timmers E (1996). Monoclonal antibody carriers to produce agglutinating reagents with bio-engineered blood group specific single chain Fv. Transfusion Medicine 6:27.
   
   
3. Bruce LJ, Zelinski T, Ridgwell K, Tanner MJ (1996). The low-incidence blood group antigen, Wda, is associated with the substitution Val557-->Met in human erythrocyte band 3 (AE1). Vox Sang. 71:118-20.
   
   
4. Jones SM, Matthew CM, Dixey J, Lovell CR, McHugh N (1996). VCAM-1 expression on endothelium in lesions from cutaneous lupus erythematosus is increased compared with systemic and localized scleroderma. Br J Dermatol. 135:678-86.
   
   
5. Balsa A, Dixey J, Sansom DM, Maddison PJ, Hall ND (1996). Differential expression of the costimulatory molecules B7.1 (CD80) and B7.2 (CD86) in rheumatoid synovial tissue. Br J Rheumatol. 35:33-7.
   
   
6. Soriano ER, Dixey J, Hall ND, Davies J, Maddison PJ (1996). Synovial tissue responses following treatment of rheumatoid arthritis with the humanized monoclonal antibody CAMPATH-1H. Arthritis Rheum. 39:181-2.
   
   
7. Hattingh C, Green F, Bubb MO, Conradie JD (1996). The incidence of IgA deficiency amongst blood donors in Kwa-Zulu Natal. S.Afr.J.Sci 92:206-209.
   

1995

1. King MJ, Holmes CH, Mushens RE, Mawby WJ, Reid ME, Scott ML (1995). Reactivity with erythroid and non-erythroid tissues of a murine monoclonal antibody to a synthetic peptide having amino acid sequence common to cytoplasmic domain of human glycophorins C and D. Brit. J. Haem, 89:440-448.
   
   
2. Goulding NJ, Dixey J, Morand EF, Dodds RA, Wilkinson LS, Pitsillides AA, Edwards JC (1995). Differential distribution of annexins-I, -II, -IV, and -VI in synovium. Ann Rheum Dis. 54:841-5.
   
   
3. Koh WH, Dunphy J, Dixey J, Calin A, McHugh N, Maddison PJ (1995). Atypical antineutrophil cytoplasmic antibodies in patients with ankylosing spondylitis. Br J Rheumatol. 34:695-6.
   
   
4. Koh WH, Dunphy J, Whyte, Dixey J, McHugh N (1995). Characterisation of anticytoplasmic antibodies and their clinical associations. Arthritis Rheum Dis. 54:269-73. 
   

1994

1. Morand EF, Jefferiss CM, Dixey J, Mitra D, Goulding NJ (1994). Impaired glucocorticoid induction of mononuclear leukocyte lipocortin-1 in rheumatoid arthritis. Arthritis Rheum. 37:207-11.
   
   
2. Eyers SA, Ridgwell K, Mawby WJ, Tanner MJ (1994). Topology and organization of human Rh (rhesus) blood group-related polypeptides. J Biol Chem. 269:6417-23.
   
   
3. Ridgwell K, Eyers SA, Mawby WJ, Anstee DJ, Tanner MJ (1994). Studies on the glycoprotein associated with Rh (rhesus) blood group antigen expression in the human red blood cell membrane. J Biol Chem. 269:6410-6.
   
   
4. Green, F (1994). Cloning the antibody Fab domain in a phage display vector. 7th Annual Symposium of the Natal Region of the Biochemical Society of South Africa (Oral presentation).

1993

1. Mushens RE, Guest AR, Scott ML (1993). Quantitation of monoclonal antibodies by ELISA. The use of purified mouse IgG and mouse IgM monoclonal antibodies as standards in a quantitative ELISA measuring monoclonal antibodies produced by cell culture. J. Immunol. Methods 162:77-83.
   
   
2. Scott ML, Voak D, Jones J, Mushens RE, Carter C, Cui Y-C, Hughes-Jones NC (1993). RUM-1: A new IgM monoclonal antibody anti-D that detects low grade D^u and all categories/varients tested except D^VI – a superior typing reagent. Transfusion 33 (Poster).
   
   
3. Bubb M, Green FA, Conradie JD, Tchernyshev B, Beyer EA, Wilchek M (1993). Natural antibodies to avidin in human serum. Immunology Letters 35:277-280.
   
   
4. Green F, Bubb M, Conradie JD (1993). The use of jacalin as a solid phase in ABO reverse grouping. Vox Sang. 65:232-238.
   

1992

1. Guest AR, Scott ML, Smythe J, Judson PA (1992). Analysis of the structure and activity of A and A,B immunoglobulin A monoclonal antibodies. Transfusion 32:239-45.
   
   
2. Ridgwell K, Spurr NK, Laguda B, MacGeoch C, Avent ND, Tanner MJ (1992). Isolation of cDNA clones for a 50 kDa glycoprotein of the human erythrocyte membrane associated with Rh (rhesus) blood-group antigen expression. Biochem J. 287:223-8.
   
   
3. Mushens RE, Bakacs T (1992). Inhibition of the classical activation pathway of complement mediated lysis by monoclonal antibodies to complement components C3c and C3d. Transfusion 32:430-4.
   
   
4. MacGeoch C, Mitchell CJ, Carritt B, Avent ND, Ridgwell K, Tanner MJ, Spurr NK (1992). Assignment of the chromosomal locus of the human 30-kDal Rh (rhesus) blood group-antigen-related protein (Rh30A) to chromosome region 1p36.13----p34. Cytogenet Cell Genet. 59:261-3.

1991

1. Green FA, Bubb MO, Conradie JD (1991). An evaluation of ABO and Rh D donor grouping by solid phase. 24th National Blood Transfusion Congress (Oral presentation).
   
   
2. Moores P, Smart E, Green F (1991). Second International Workshop on Monoclonal Antibodies for Blood Group and Related Antigens. 24th National Blood Transfusion Congress (co-author).
   

1990

1. Mushens RE, Scott ML (1990). A fast and efficient method for quantification of monoclonal antibodies in an ELISA using a novel incubation system. J. Immunol. Methods 131, 83-89.
   
   
2. Reid ME, Mawby WJ, Scott ML, Mushens RE, King MJ, Holmes CH (1990). Use of a monoclonal antibody to the c-terminus of Glycophorin C to study the distribution of this glycoprotein in human tissues. Transfusion Medicine 1(Suppl. 1):66 (Abstract).
   
   
3. Scott ML, Guest AR, Mushens RE (1990). Assessment of components of papain and bromelain in serological and biochemical assays. Transfusion Medicine 1: F10.
   
   
4. Mushens RE, Dawes BJ, Scott ML (1990). Comparison of ELISA, autoanalyzer and manual serological techniques for the quantitation of monoclonal anti-D. Transfusion Medicine 1(Suppl. 1):61.
   
   
5. Avent ND, Ridgwell K, Tanner MJ, Anstee DJ (1990). cDNA cloning of a 30 kDa erythrocyte membrane protein associated with Rh (Rhesus)-blood-group-antigen expression. Biochem J. 271:821-5.
   
   
6. Mallinson G, Anstee DJ, Avent ND, Ridgwell K, Tanner MJ, Daniels GL, Tippett P, von dem Borne AE (1990). Murine monoclonal antibody MB-2D10 recognizes Rh-related glycoproteins in the human red cell membrane. Transfusion 30:222-5.
   
   
7. Moores PP, Smart E, Green F (1990). Mabs workshop studies with monoclonal ABO, anti-Lewis and anti-I antibodies: In: Chester, M.A. et al (eds):53. Proceedings of the Second International Workshop.
   
   
8. Moores PP, Smart E, Green F (1990). Mabs workshop studies with monoclonal anti-M, anti-N, anti-Lu, anti-RBC(CD44), anti-In(Lu), anti-K2 and anti-Jkb antibodies: In: Chester, M.A. et al (eds):104. Proceedings of the Second International Workshop.
   
   
9. Moores PP, Smart E, Green F (1990). Mabs workshop studies with monoclonal anti-Rh antibodies: In: Chester, M.A. et al (eds):163. Proceedings of the Second International Workshop.
   

1989

1. Green FA, Bubb MO, Conradie JD (1989). Solid phase ABO and D grouping. 23rd National Blood Transfusion Congress (Oral presentation).
   
   
2. Smart EA, Green F, Mulvihal M (1989). Red cell type St(a+) - The first reported example in Southern Africa. 23rd National Blood Transfusion Congress (Poster).

1988

1. Avent ND, Ridgwell K, Mawby WJ, Tanner MJ, Anstee DJ, Kumpel B (1988). Protein-sequence studies on Rh-related polypeptides suggest the presence of at least two groups of proteins which associate in the human red-cell membrane. Biochem J. 256:1043-6.
   
   
2. Tanner MJ, Anstee DJ, Mallinson G, Ridgwell K, Martin PG, Avent ND, Parsons SF (1988). Effect of endoglycosidase F-peptidyl N-glycosidase F preparations on the surface components of the human erythrocyte. Carbohydr Res.178:203-12.
   
   
3. Green, F. and Prior, C. (1988) Haemoglobin cut-off levels for blood donation - an objective approach. 22nd National Blood Transfusion Congress, Cape Town, 7-9 September 1988. (Oral presentation).
   
   
4. Green FA, Bubb MO, Conradie JD (1988). Probing the sialoglycoproteins of red cell membranes with lectins by western blotting. 22nd National Blood Transfusion Congress (Oral presentation).
   

1987

1. Scott ML, Guest AR, King MJ, Chambers KM, Davis ME, Brazier DM (1987). Characterisation of anti-A monoclonals by liquid-phase and solid-phase serology and radioimmunoassay. Rev Fr Transfus Immunohematol. 30:443-50. No abstract available.
   
   
2. Scott ML, Guest AR, King MJ, Chambers KM, Davis ME, Brazier DM (1987). Characterisation of anti-B and anti-A + B monoclonals by liquid-phase and solid-phase serology and radioimmunoassay. Rev Fr Transfus Immunohematol. 30:515-22. No abstract available.
   
   
3. Reid ME, Anstee DJ, Tanner MJ, Ridgwell K, Nurse GT (1987). Structural relationships between human erythrocyte sialoglycoproteins beta and gamma and abnormal sialoglycoproteins found in certain rare human erythrocyte variants lacking the Gerbich blood-group antigen(s). Biochem J. 244:123-8.
   
   
4. Green F, Prior C (1987). Screening for beta-thalassaemia trait in the Asian donor population of the Natal Blood Transfusion Service. 21st National Blood Transfusion Congress (Oral presentation).

1986

1. Green F (1986). An apparent new variant haptoglobin found in the Zulu and Coloured populations of Natal. 20th National Blood Transfusion Congress (Oral presentation).
   

1984

1. Ridgwell K, Tanner MJ, Anstee DJ (1984). The Wrb antigen in Sta-positive and Dantu-positive human erythrocytes. J Immunogenet. 11:365-70.
   
   
2. Ridgwell K, Tanner MJ, Anstee DJ (1984). The Rhesus (D) polypeptide is linked to the human erythrocyte cytoskeleton. FEBS Lett. 174:7-10.
   
   
3. Anstee DJ, Ridgwell K, Tanner MJ, Daniels GL, Parsons SF (1984). Individuals lacking the Gerbich blood-group antigen have alterations in the human erythrocyte membrane sialoglycoproteins beta and gamma. Biochem J. 221:97-104.
   
   
4. Anstee DJ, Parsons SF, Ridgwell K, Tanner MJ, Merry AH, Thomson EE, Judson PA, Johnson P, Bates S, Fraser ID (1984). Two individuals with elliptocytic red cells apparently lack three minor erythrocyte membrane sialoglycoproteins. Biochem J. 218:615-9.

1983

1. Ridgwell K, Roberts SJ, Tanner MJ, Anstee DJ (1983). Absence of two membrane proteins containing extracellular thiol groups in Rhnull human erythrocytes. Biochem J. 213:267-9.
   
   
2. Ridgwell K, Tanner MJ, Anstee DJ (1983). The Wrb antigen, a receptor for Plasmodium falciparum malaria, is located on a helical region of the major membrane sialoglycoprotein of human red blood cells. Biochem J. 209:273-6.

1981

1. Kenny AJ, Fulcher IS, Ridgwell K, Ingram J (1981). Microvillar membrane neutral endopeptidases. Acta Biol Med Ger. 40:1465-71.

Ridgwell K et al. Recombinant antigens and antibodies/designer red cells. BioRad.  (2011 – 2016). £1,227,897

Ridgwell K et.al. Development of soluble recombinant human granulocyte antigens. NHSBT PG07/7(2008-2010). £70,657

Ridgwell K et.al. Development of soluble recombinant human granulocyte antigens. NHSBT PG03/8 (2004 – 2007). £187,619

Ridgwell K., Scott M. Development of recombinant Rh, Kidd and Colton blood group antigens for antibody screening and identification. DiaMed (2005 – 2008). £192,000